# Clinical Performance Evaluation of the Bio-Self™ COVID-19 Antigen Home Test

> **NCT05334758** · NA · COMPLETED · sponsor: **BioTeke USA, LLC** · enrollment: 282 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DEVICE:** Bio-Self COVID-19 Antigen Home Test
- **DEVICE:** Standard of Care COVID-19 Test
- **DIAGNOSTIC_TEST:** RT-PCR Test

## Key facts

- **NCT ID:** NCT05334758
- **Lead sponsor:** BioTeke USA, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-12
- **Primary completion:** 2022-07-25
- **Final completion:** 2022-07-25
- **Target enrollment:** 282 (ACTUAL)
- **Last updated:** 2024-03-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05334758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05334758, "Clinical Performance Evaluation of the Bio-Self™ COVID-19 Antigen Home Test". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05334758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*